HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phenobarbital minimally alters plasma concentrations of losartan and its active metabolite E-3174.

Abstract
Losartan, a selective angiotensin II (AT1) receptor antagonist for hypertension, is metabolized to an active carboxylic acid metabolite, E-3174, which has a longer half-life. To investigate the effects of induction of cytochrome P450 on the metabolism of losartan, we evaluated the effects of phenobarbital on the plasma profiles of losartan and E-3174 in 15 healthy male subjects. Ten subjects received a single 100 mg oral dose of losartan before and during phenobarbital administration (100 mg/day for 16 days), and five subjects received losartan before and during placebo. Urinary excretion of 6-beta-hydroxycortisol (relative to 17-hydroxycorticosteroids) was measured as an endogenous marker of cytochrome P450 induction. The geometric mean area under the plasma concentration-time curve ratios (with/without phenobarbital and 90% confidence intervals) for losartan and its metabolite (E-3174) were 0.795 (0.723, 0.875) and 0.799 (0.778, 0.820), respectively, indicating that phenobarbital treatment significantly but to a clinically minor extent reduced plasma concentrations of losartan and E-3174 (p<0.01). Half-life values of losartan and E-3174 were unchanged. The ratio of 6-beta-hydroxycortisol to 17-hydroxycorticosteroids doubled in the phenobarbital group (p < 0.001) and did not change appreciably in the placebo group.
AuthorsM R Goldberg, M W Lo, P J Deutsch, S E Wilson, E J McWilliams, J B McCrea
JournalClinical pharmacology and therapeutics (Clin Pharmacol Ther) Vol. 59 Issue 3 Pg. 268-74 (Mar 1996) ISSN: 0009-9236 [Print] United States
PMID8653989 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticonvulsants
  • Antihypertensive Agents
  • Biphenyl Compounds
  • Hypnotics and Sedatives
  • Imidazoles
  • Tetrazoles
  • 6 beta-hydroxycortisol
  • Cytochrome P-450 Enzyme System
  • Mixed Function Oxygenases
  • CYP3A protein, human
  • Cytochrome P-450 CYP3A
  • losartan carboxylic acid
  • Losartan
  • Hydrocortisone
  • Phenobarbital
Topics
  • Adult
  • Anticonvulsants (pharmacology)
  • Antihypertensive Agents (blood, pharmacokinetics)
  • Biphenyl Compounds (blood, pharmacokinetics)
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 Enzyme System (biosynthesis)
  • Enzyme Induction (drug effects)
  • Humans
  • Hydrocortisone (analogs & derivatives, urine)
  • Hypnotics and Sedatives (pharmacology)
  • Imidazoles (blood, pharmacokinetics)
  • Losartan
  • Male
  • Mixed Function Oxygenases (biosynthesis)
  • Phenobarbital (pharmacology)
  • Reference Values
  • Single-Blind Method
  • Tetrazoles (blood, pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: